Elastic tape reduces dyspnea and improves health status in the short term in nonobese COPD males: A randomized controlled trial

Nenhuma Miniatura disponível
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2024
Título da Revista
ISSN da Revista
Título do Volume
Editora
W B SAUNDERS CO LTD
Citação
RESPIRATORY MEDICINE, v.221, article ID 107459, 7p, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction and objectives: The elastic tape (ET) is a novel intervention that acutely improves exercise capacity in laboratory tests; however, its effect on a patient's daily life remains unknown. This randomized controlled trial evaluated the effects of ET on daily life physical activity (DLPA), dyspnea symptoms, health status, and health -related quality of life (HRQoL) in individuals with COPD. Methods: Fifty males with moderate to very severe COPD were randomly assigned to an intervention group (ETG, n = 25), receiving ET on the chest wall and abdomen, or a control group (CG, n = 25). The intervention was for 14 days. DLPA (accelerometry; steps per day, and sedentary time), dyspnea symptoms (transition dyspnea index, TDI; and modified Medical Research Council, mMRC), health status (COPD assessment test, CAT), and health -related quality of life (HRQoL, CRQ) were evaluated at baseline and on Day 21 after the intervention. Results: No change in the DLPA was observed in between-group comparison. CG presented a reduction in step counts after 21days (-707,p <0.05) while ETG. maintained (-114,p > 0.94). However, ET reduced dyspnea symptoms in all TDI domains (functional, task, and effort) and on the mMRC scale after 14 days compared with CG (p < 0.01). Also, the ETG improved CAT score compared to the CG, reaching minimal clinical important difference (MCID) (-4.4 score, p <0.01). The ETG also improved in most CRQ domains reaching MCID after 21 days. Conclusions: ET does not modify DLPA but reduces dyspnea and improves health status and HRQoL in nonobese males with moderate to very severe COPD in the short term. This novel and low-cost intervention improves COPD symptoms.
Palavras-chave
COPD, Dyspnea, Health status, Quality of life, Physical activity, Elastic tape, Relieve symptoms
Referências
  1. Alma H, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00412-2018
  2. Alqahtani JS, 2021, FRONT BIOSCI-LANDMRK, V26, P246, DOI 10.52586/4938
  3. Amorim PB, 2014, J BRAS PNEUMOL, V40, P504, DOI 10.1590/S1806-37132014000500006
  4. Demeyer H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154587
  5. Dodd JW, 2011, THORAX, V66, P425, DOI 10.1136/thx.2010.156372
  6. Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222
  7. Garcia-Pachon E, 2006, INT J CLIN PRACT, V60, P514, DOI 10.1111/j.1368-5031.2006.00850.x
  8. Gimeno-Santos E, 2014, THORAX, V69, P731, DOI 10.1136/thoraxjnl-2013-204763
  9. ( GOLD) GIfCOLD, 2023, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2022 Report)
  10. Karloh M, 2020, COPD, V17, P343, DOI 10.1080/15412555.2020.1790511
  11. Lee J, 2018, HEART LUNG, V47, P149, DOI 10.1016/j.hrtlng.2017.12.007
  12. Mahler D.A., 2015, Am. J. Respir. Crit. Care Med., P191
  13. Mahler DA, 2015, CHEST, V147, P232, DOI 10.1378/chest.14-0800
  14. McCarthy B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub3
  15. Ora J, 2011, J APPL PHYSIOL, V111, P10, DOI 10.1152/japplphysiol.01131.2010
  16. Pereira MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182417
  17. Pinto TF, 2020, J APPL PHYSIOL, V129, P492, DOI 10.1152/japplphysiol.00690.2019
  18. Porras DC, 2017, J APPL PHYSIOL, V122, P1106, DOI 10.1152/japplphysiol.00508.2016
  19. Schulz KF, 2011, DEUT MED WOCHENSCHR, V136, pE26, DOI 10.1055/s-0031-1272983
  20. Smid DE, 2017, J AM MED DIR ASSOC, V18, P53, DOI 10.1016/j.jamda.2016.08.002
  21. Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3
  22. Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98
  23. Vogelmeier C.F., 2020, Respir. Med., P166
  24. Vogelmeier CF, 2020, RESP MED, V166, DOI 10.1016/j.rmed.2020.105938
  25. von Leupoldt A, 2017, COPD, V14, P66, DOI 10.1080/15412555.2016.1246522
  26. Wada JT, 2016, INT J CHRONIC OBSTR, V11, P2691, DOI 10.2147/COPD.S114548
  27. Xavier RF, 2019, LUNG, V197, P37, DOI 10.1007/s00408-018-0177-8
  28. Yasui H, 2019, RESP MED, V146, P76, DOI 10.1016/j.rmed.2018.11.020
  29. Zhang F, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000024930